ACET — ADICET BIO INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About ADICET BIO INC (ACET)
ADICET BIO INC (ACET) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $3M. Across recent filings, tracked investors recorded 1 new positions, 1 increased, 1 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ACET
How many top investors track ACET
Only 1 tracked investor report this position.
ACET Ownership Composition
How ADICET BIO INC is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting ACET
- Ken GriffinMar 31, 2026Citadel AdvisorsShares381.8KValue$2.6M% Portfolio0.00%
Recent activity
- Increased$2.6M(254.15%)May 15, 2026
- Reduced$907.8K(-81.54%)Feb 17, 2026
- New$473.1KNov 14, 2025
Frequently asked questions
- How many institutional investors hold ACET?
- 1 tracked institutional investor disclosed a position in ACET (ADICET BIO INC) in their most recent 13F filing.
- Who is the largest institutional holder of ACET?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in ACET, valued at $3M.
- Did institutional ownership of ACET increase or decrease?
- Across recent 13F filings, tracked investors recorded 1 new positions, 1 increased, 1 reduced, and 0 fully exited ACET.
- Where does this ACET ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.